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============

Emotion and mood are pervasive and internalized in our daily life and impose a huge impact on physical well-being, perception, experience, judgement, and behavior. Neuroscientists have launched projects to fill the gaps in our understanding on neural mechanisms of emotion and mood. The limbic system, composed of a set of brain structures including amygdala, hippocampus, thalamus, and hypothalamus, is well known for the regulation of emotion and mood. However, there is still controversy with regard to the basic nature and the neural processes involved in the generation and representation of emotion and mood. This special issue is composed of 5 review articles and 1 original article, with a focus on the topic of emotion and mood.

Hypothalamus has a central role in integrating the neuroendocrine-immune responses to stress. [Prof. Bao and Prof. Swaab](https://doi.org/doi:10.1016/j.ibror.2018.11.008){#intr0005} presented a review focusing on changes in the human hypothalamus in depression and proposed a model that illustrates the network of neurotransmitters and neuromodulators involved in the pathogenesis of mood disorders. Corticotropin-releasing hormone (CRH) neurons in the hypothalamic paraventricular nucleus are responsible for determining the state of hypothalamic-pituitary-adrenal axis and play a key role in stress response. [Prof. Zhou and Prof. Fang](https://doi.org/doi:10.1016/j.ibror.2018.08.003){#intr0010} summarized the recent progress in CRH transcriptional regulation from DNA methylation to classic transcriptional factor regulation. They further proposed the imbalance of multiple paired receptors in regulating the activity of CRH neurons as one possible etiology of depression. By analyzing the impact of different types of stress on long-term potentiation and long-term depression, [Prof. Richter-Levin and Prof. Xu](https://doi.org/doi:10.1016/j.ibror.2018.04.001){#intr0015} defined the casual relationship between stress and major depressive disorders. [Prof. Zhu and colleagues](https://doi.org/doi:10.1016/j.ibror.2018.11.004){#intr0020} in their review emphasized the physiological function of neuronal nitric oxide synthase (nNOS) in the brain and the signal mechanisms of nNoS underlying the pathophysiology of aﬀ ;ective disorders. [Prof. Fasipe](https://doi.org/doi:10.1016/j.ibror.2019.01.001){#intr0025} reviewed emerging drugs for the management of depression disorders. The potential of atypical antipsychotics and NMDA receptor blockers as antidepressant agents was also probed. The original report from [Prof. Liu and colleagues](https://doi.org/doi:10.1016/j.ibror.2019.03.001){#intr0030} delineated a projection map of GABAergic neurons from amygdala to the brainstem ventrolateral periaqueductal grey and to the medial prefrontal cortex by employing a VGAT-Cre transgenic line and cre-inducible retrograde AAV tracer. Their results suggest the involvement of amygdala GABA neurons in triggering emotionally induced cataplexy in sleep disorder, narcolepsy.

This special issue provides a more comprehensive understanding in the neurobiology of mood as well as the etiology of affective disorders, thus benefiting the prevention and therapy of mood disorders.
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